title: [Effectiveness of therapeutic interventions in obesity].
abstract: Obesity is a chronic disease resulting from various genetic factors and environmental conditions (nutrition, sedentary life-style, psychological factors). The importance of prevention and therapy of obesity is emerging because of the high prevalence of metabolic complications. The first goal of any therapy must be a stabilisation of weight, followed by a reduction of body weight. Any intervention must be long-acting. Short-acting therapies (diets) result in a regain of body weight in over 90%. The most effective therapy is an integrative concept basing on: change of nutrition by reduction of fat and carbohydrate intake (daily deficit of 500-1000 kcal). psychotherapeutic approach, targeting a long-term change of eating-behaviour and life-style, avoiding guilt feelings. encouraging physical activity. Drugs (Orlistat, Sibutramin) may be helpful in selected cases as a part of a limited treatment, they do not replace changes in lifestyle. Surgical interventions (gastric banding, gastric bypass) can be considered in morbid obesity with the presence of metabolic complications, as they are the most effective way of weight reduction.
authors.affiliation: Universitätskliniken, Kantonsspital, Basel.
authors.forename: R
authors.initials: R
authors.lastname: Stöckli
authors.forename: U
authors.initials: U
authors.lastname: Keller
mesh_terms: D001521:Behavior Therapy; D003131:Combined Modality Therapy; D003430:Cross-Sectional Studies; D003503:Cyclobutanes / Q000009:adverse effects / Q000627:therapeutic use; D004038:Diet, Reducing; D015444:Exercise; D015391:Gastroplasty; D006801:Humans; D015994:Incidence; D007783:Lactones / Q000009:adverse effects / Q000627:therapeutic use; D008055:Lipids / Q000097:blood; D009765:Obesity / Q000097:blood / Q000453:epidemiology / Q000628:therapy*; D000077403:Orlistat; D013557:Switzerland; D016896:Treatment Outcome
chemical_list: D003503:Cyclobutanes; D007783:Lactones; D008055:Lipids; D000077403:Orlistat; C058254:sibutramine